Items where SHU Author is "Lawson, Kim"
|Up a level|
Number of items: 12.
BEARD, S M, ROSKELL, N, LE, T K, ZHAO, Y, COLEMAN, A, ANG, D and LAWSON, Kim (2011). Cost effectiveness of duloxetine in the treatment of fibromyalgia in the United States. Journal of medical economics.
VAHABI, B, LAWSON, Kim, MCKAY, Neil and SELLERS, Donna (2011). Phasic activity of urinary bladder smooth muscle in the streptozotocin-induced diabetic rat: effect of potassium channel modulators. European Journal of Pharmacology, 660 (2-3), 431-437.
VAHABI, B., MCKAY, N. G., LAWSON, K. and SELLERS, D. J. (2010). The role of c-kit-positive interstitial cells in mediating phasic contractions of bladder strips from streptozotocin-induced diabetic rats. BJU International.
VAHABI, B, LAWSON, Kim, MCKAY, Neil and SELLERS, Donna (2009). Cholinergic modulation of spontaneous activity in bladder strips from the diabetic rat : effect of the mucosa. European Eurology Supplements, 8 (4), p. 177.
LAWSON, K. (2009). Pregabalin and Fibromyalgia Syndrome: A Treatment Option. Clinical Medicine: Therapeutics, 1, 809-824.
LAWSON, K., SHAWCROSS, E. and RAPHAEL, J. H. (2008). Function of Potassium Channels in Blood Mononuclear Cells of Patients with Fibromyalgia. Journal of pain management, 1 (3), 289-293.
VAHABI, B., MCKAY, Neil, LAWSON, Kim and SELLERS, Donna (2008). Identification of C-Kit positive cells in rat urinary bladder and characterization of their functional role in spontaneous activity in control and diabetic bladders. European Eurology Supplements, 7 (3), p. 181.
SELLERS, Donna, MCKAY, Neil and LAWSON, Kim (2008). Inhibitory effect of cromakalim on muscarinic receptor-stimulated spontaneous activity in diabetic rat bladder. Fundamental & Clinical Pharmacology, 22 (Suppl ), p34.
LAWSON, K., SHAWCROSS, E. and RAPHAEL, J. H. (2008). Insensitivity of Lymphocytes of Patients with Neuropathic Pain Conditions to K+Channel Blockers. Journal of pain management, 1 (1), 43-48.
LAWSON, K. (2008). Pharmacological treatments of fibromyalgia: Do complex conditions need complex therapies? Drug Discovery Today, 13 (7-8), 333-340.
LAWSON, K. (2008). Treatment options and patient perspectives in the management of fibromyalgia: future trends. Neuropsychiatric disease and treatment, 4 (6), 1059-1071.
MCKAY, Neil, KIRBY, R W and LAWSON, Kim (2008). Rubidium efflux as a tool for the pharmacological characterisation of compounds with BK channel opening properties. In: LIPPIAT, Jonathan D, (ed.) Potassium channels : methods and protocols. Methods in Molecular Biology (491). Humana Press, 267-277.